As pharmaceutical companies increasingly digitize data and store it online, they become more susceptible to pharmaceutical cyberattacks. While the industry is comprised of a number of sub-industries with different business models and technology needs, they all must control extremely sensitive and valuable information and ensure an effective security framework. Drug and device manufacturers and biotech companies retain proprietary data ranging from secret formulas for patented drugs, to patient and customer information, to scientific research and advancements.

The industry is being attacked by adversaries’ adept at exploiting vulnerabilities and carrying out disruptive cyber campaigns. Cyber threats are used by a variety of bad actors with a range of intended system consequences. These attackers are better resourced and more capable of accomplishing disruption than ever before. In addition to hackers seeking financial gain, pharma companies also have to worry about the full capabilities of nation-states or other pharmaceutical companies with state sponsorship.

Consequences of a successful breach are dire and may include contaminated drugs, stolen intellectual property (IP), needing to repeat clinical trials, damaged reputation, downtime, litigation, and lost revenue.

In this webinar, we will explore the top threats and challenges pharmaceutical companies must overcome when securing their networks, and what’s driving them.